ADMA Biologics Inc ADMA

9.38 (0.14) (1.47%) as of 25 Sep
Market cap
$2.1B
P/E
13.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
87.63 103.15 51.35 86.52 51.09 55.92 26.75 22.75 43.11 15.31
Receivables
158.43 50.00 27.42 15.51 28.58 13.24 3.47 1.39 3.88 1.02
Inventory
206.47 170.24 172.91 163.28 124.72 81.54 53.06 18.62 12.63 5.02
Other current assets
6.53 — — 5.10 4.34 3.05 2.53 1.77 1.50 0.31
Total current assets
466.51 331.41 257.01 270.40 208.73 153.74 85.82 44.53 62.34 21.66
Property, Plant, Equpment (Net)
65.06 54.71 53.84 58.26 50.94 41.59 31.74 30.12 30.47 2.00
Goodwill and Intangible Assets (Total)
4.16 3.99 4.03 4.54 5.26 5.97 6.69 7.53 8.38 —
Long Term Assets (Tax, Deferred)
73.26 84.28 — — — — — — — —
Long-term assets (Other)
8.60 5.66 4.67 4.77 4.07 2.11 1.60 6.70 6.83 0.03
Total non-current assets
157.73 157.27 72.17 78.06 67.52 53.93 41.27 44.35 45.68 2.03
Total Assets
624.24 488.68 329.18 348.46 276.25 207.67 127.09 88.88 108.02 23.69
Notes Payable
2.81 — — — — — — — — 6.11
Accounts Payable
22.52 20.22 15.66 13.23 12.43 11.07 9.17 5.90 5.92 2.56
Accrued Expenses
40.47 34.11 32.92 24.99 17.22 8.37 4.48 3.55 3.38 2.39
Current Part of Debt
— — — 0.91 0.59 0.37 0.23 0.03 — 6.13
Current Part of Capital Lease
1.10 1.22 1.05 0.91 0.59 0.37 0.23 0.03 — —
Current Revenue (Deferred)
— 0.14 0.18 0.14 0.14 0.14 0.14 0.14 0.14 0.15
Other current liabilities
2.65 — — 25.13 17.36 8.51 4.62 3.69 3.52 0.02
Total current liabilities
69.54 55.54 49.81 39.27 30.38 19.95 14.03 9.63 9.44 11.22
Long Term Debt (Total)
75.98 80.90 140.37 153.54 102.33 97.30 84.50 41.43 40.21 12.32
Non-current Revenue (Deferred)
1.41 1.55 1.69 1.83 1.98 2.12 2.26 2.40 2.55 2.69
Non-current Liabilities (Other)
— 1.67 2.11 1.85 0.40 0.05 0.11 15.64 15.49 1.91
Total non-current liabilities
77.38 84.12 144.17 157.22 104.70 99.48 86.87 59.48 58.25 16.92
Total liabilities
146.92 139.66 193.98 196.49 135.08 119.42 100.90 69.11 67.69 28.14
Additional Paid In Capital
671.04 657.58 641.44 629.97 553.27 428.70 290.90 236.20 191.02 102.48
Common Stock (Net)
0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.00 0.00
Retained Earnings
(161.65) (308.58) (506.26) (478.02) (412.11) (340.47) (264.72) (216.44) (150.69) (106.93)
Treasury Stock
32.09 0.00 — — — — — — — —
Common Equity (Total)
477.32 349.02 135.21 151.97 141.17 88.25 26.19 19.77 40.33 (4.46)
Shareholders Equity (Total)
477.32 349.02 135.21 151.97 141.17 88.25 26.19 19.77 40.33 (4.46)
Shareholders Equity and Liabilities (Total)
624.24 488.68 329.18 348.46 276.25 207.67 127.09 88.88 108.02 23.69
Shares (Common)
237.87 236.62 226.06 221.82 195.81 104.90 59.32 46.35 45.32 12.89
Shareholders Equity (Tangible)
473.16 345.03 131.18 147.43 135.91 82.28 19.50 12.24 31.95 (4.46)
Net Debt
(11.65) (22.25) 89.02 67.92 51.83 41.75 57.98 18.71 (2.90) 3.14
Total Debt
75.98 80.90 140.37 154.44 102.92 97.67 84.73 41.46 40.21 18.45

Fold the line items

In millions of $ except per-share values · columns are period end dates